The Cannigma

MAY 19, 2021

Japan has some of the harshest drug policies on Earth, including for cannabis — and is one of the worst places on Earth to get arrested on marijuana possession charges. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

MMJ Recs

DECEMBER 22, 2023

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. These campaigns focus on dispelling myths, highlighting success stories, and educating the public about the science behind cannabis-based treatments.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. For the regulated community, this is a trend worth watching.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Forward-looking statements.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

JUNE 19, 2022

The new center is designed to formalize a network of experts across the university based in a range of academic departments as well as existing centers focused on drug policy and substance misuse prevention and recovery. Alan Davis. Jason Slot. Our capacity to reach so many makes this commitment essential.”.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

MARCH 29, 2022

With Mike, MAPS PBC is taking another major step in building a world-class pharmaceutical organization capable of meeting the enormous need for novel treatments for PTSD and other mental health conditions. Dawn remains a faculty member at Penn directing the QA course of study for the ITMAT Masters program. Amy Emerson , CEO, MAPS PBC.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. TOKI currently offers several CBD products, which may be used in connection with the treatment of a number of ailments and for general wellness purposes.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The city council unanimously approved a resolution allowing consumers at The Fairbanks Cut to consume cannabis on-site as part of the state’s recreational cannabis program.

Banking 45

Banking Research and Development Legislation Programs 45

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. We have a program called Integrative Medicine and Residency that’s been adopted by, I think, over 100 residencies in North America, some in Europe as well.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. But what happens to the medical programs and access and probably in ways that I don’t even know what to ask?

Legalization 128

Legalization Patients Education Dispensary 128

Canna Law Blog

MAY 7, 2020

This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research. for various studies, including FDA-approved clinical trials. These cannabis products are used by researchers in the U.S.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

The Cannigma

MAY 7, 2021

Europe’s obviously come a long way and most of the countries on the continent have varying degrees of medical programs alongside going hemp industries but can you start by giving a quick overview of where Europe is in comparison to North America but also your thoughts on why the momentum seems to be different? MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. Psychedelic Alpha Policy Map.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. Andrew Yang. Amanda Feilding.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

DECEMBER 28, 2018

The facility, which has a “zero tolerance” policy on “drug use” (except alcohol and pharmaceuticals) kicked Flickner to the curb in the freezing cold despite the fact that he uses a wheelchair and has a doctor’s recommendation to consume medical cannabis per state law.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Veriheal

JULY 18, 2023

The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. For non-US citizens, Malyshev explains, this can result in a lifetime ban from entry into the US under current policy.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

Presidents Barack Obama and Donald Trump have voiced support for state governments deciding their own policies. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. So, in seven years why hasn’t Kentucky moved forward?

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JUNE 30, 2019

New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. The Federal Aviation Administration issued a bulletin clarifying its cannabis and CBD policy for pilots.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Veriheal

JANUARY 28, 2022

Rather, it was only an indication that CBD’s ability to fight COVID-19 warranted further research under more rigorous clinical trials. Nevertheless, CBD and other cannabis compounds may still prove to be effective COVID treatments. The revenue from its excise tax will go to law enforcement and veteran health programs.

Dispensary 98

Dispensary Clinical Trials CBD Legalization 98

Cannabis Law Report

JANUARY 14, 2020

Senior Policy Advisor, Diversion Control Division. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. 171 , the “Legitimate Use of Medicinal Marihuana Act” or the “LUMMA” H.R. 601 , the “Medical Cannabis Research Act of 2019” H.R. Douglas Throckmorton, M.D.

Clinical Trials 69

Clinical Trials Programs Access DEA 69